<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Cardiomyopathies (Dr. Nyamu)</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams' // Use AMS numbering of equations
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="cardiology-cardiomyopathies-9.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 65.4%;"></div> <!-- Set percentage dynamically with static value for this chunk -->
                        </div>
                       <span class="progress-text">Lecture 34 of 52</span> <!-- Update text with static value for this chunk -->
                    </div>
                    <a href="cardiology-cardiomyopathies-9A-styled.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">CARDIOMYOPATHY</h1>
                <p>By: Dr. Murithi Nyamu Physician/ Cardiologist</p>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                <!-- START: intro-classification -->
                <section id="intro-classification" class="content-section" aria-labelledby="section-heading-1">
                    <h2 id="section-heading-1" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Cardiomyopathies: Definition and Classification</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Definition: diseases of heart muscle</li>
                            <li>1980 WHO: unknown causes
                                <ul>
                                    <li>Not clinically relevant</li>
                                </ul>
                            </li>
                            <li>1995 WHO: "diseases of the myocardium associated with cardiac dysfunction"
                                <ul>
                                    <li>pathophysiology</li>
                                    <li>each with multiple etiologies</li>
                                </ul>
                            </li>
                        </ul>
                        <h3 class="subsection-heading">WHO Classification</h3>
                        <p>anatomy & physiology of the LV</p>
                        <ol>
                            <li>Dilated
                                <ul>
                                    <li>Enlarged</li>
                                    <li>Systolic dysfunction</li>
                                </ul>
                            </li>
                            <li>Hypertrophic
                                <ul>
                                    <li>Thickened</li>
                                    <li>Diastolic dysfunction</li>
                                </ul>
                            </li>
                            <li>Restrictive
                                <ul>
                                    <li>Diastolic dysfunction</li>
                                </ul>
                            </li>
                            <li>Arrhythmogenic RV dysplasia
                                <ul>
                                    <li>Fibrofatty replacement</li>
                                </ul>
                            </li>
                            <li>Unclassified
                                <ul>
                                    <li>Fibroelastosis</li>
                                    <li>LV noncompaction</li>
                                </ul>
                            </li>
                        </ol>
                        <p><small>Reference: Circ 93:841, 1996</small></p>
                    </div>
                </section>
                <!-- END: intro-classification -->

                <!-- START: etiologies -->
                <section id="etiologies" class="content-section" aria-labelledby="section-heading-2">
                    <h2 id="section-heading-2" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Cardiomyopathy: Specific Etiologies</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Ischemic</li>
                            <li>Valvular</li>
                            <li>Hypertensive</li>
                            <li>Inflammatory</li>
                            <li>Metabolic</li>
                            <li>Inherited</li>
                            <li>Toxic reactions</li>
                            <li>Peripartum</li>
                        </ul>
                        <figure>
                            <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-04-1.jpg" alt="Illustration of a heart with thinned and scarred tissue, indicative of ischemic cardiomyopathy." class="content-image">
                            <figcaption>Ischemic: thinned, scarred tissue</figcaption>
                        </figure>
                    </div>
                </section>
                <!-- END: etiologies -->
                
                <!-- START: dilated-cardiomyopathy -->
                <section id="dilated-cardiomyopathy" class="content-section" aria-labelledby="section-heading-3">
                    <h2 id="section-heading-3" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Dilated Cardiomyopathy</span>
                    </h2>
                    <div class="content-card">
                        <p>Dilation and impaired contraction of ventricles:</p>
                        <ul>
                            <li>Reduced systolic function with or without heart failure</li>
                            <li>Characterized by myocyte damage</li>
                            <li>Multiple etiologies with similar resultant pathophysiology</li>
                            <li>Majority of cases are idiopathic</li>
                            <li>incidence of idiopathic dilated CM 5-8/100,000</li>
                            <li>incidence likely higher due to mild, asymptomatic cases</li>
                            <li>3X more prevalent among males and African-Americans</li>
                        </ul>
                        <h3 class="subsection-heading">DCM: Etiology</h3>
                        <ul>
                            <li>Ischemic</li>
                            <li>Valvular</li>
                            <li>Hypertensive</li>
                            <li>Familial</li>
                            <li>Idiopathic</li>
                            <li>Inflammatory
                                <ul>
                                    <li>Infectious
                                        <ul>
                                            <li>Viral - picornovirus, Cox B, CMV, HIV</li>
                                            <li>Ricketsial - Lyme Disease</li>
                                            <li>Parasitic - Chagas' Disease, Toxoplasmosis</li>
                                        </ul>
                                    </li>
                                    <li>Non-infectious
                                        <ul>
                                            <li>Collagen Vascular Disease (SLE, RA)</li>
                                            <li>Peripartum</li>
                                        </ul>
                                    </li>
                                </ul>
                            </li>
                            <li>Toxic
                                <ul>
                                    <li>Alcohol, Anthracyclins (adriamycin), Cocaine</li>
                                </ul>
                            </li>
                            <li>Metabolic
                                <ul>
                                    <li>Endocrine -thyroid dz, pheochromocytoma, DM, acromegaly</li>
                                    <li>Nutritional
                                        <ul>
                                            <li>Thiamine, selenium, carnitine</li>
                                        </ul>
                                    </li>
                                </ul>
                            </li>
                            <li>Neuromuscular (Duchene's Muscular Dystrophy--x-linked)</li>
                        </ul>
                        <h3 class="subsection-heading">DCM: Infectious</h3>
                        <h4>Acute viral myocarditis</h4>
                        <ul>
                            <li>Coxsackie B or echovirus</li>
                            <li>Self-limited infection in young people</li>
                            <li>Mechanism?:
                                <ul>
                                    <li>Myocyte cell death and fibrosis</li>
                                    <li>Immune mediated injury</li>
                                </ul>
                            </li>
                            <li>BUT:
                                <ul>
                                    <li>No change with immunosuppressive drugs</li>
                                </ul>
                            </li>
                        </ul>
                        <h3 class="subsection-heading">DCM: toxic</h3>
                        <h4>Alcoholic cardiomyopathy</h4>
                        <ul>
                            <li>Chronic use</li>
                            <li>Reversible with abstinence</li>
                            <li>Mechanism?:
                                <ul>
                                    <li>Myocyte cell death and fibrosis</li>
                                    <li>Directly inhibits:
                                        <ul>
                                            <li>mitochondrial oxidative phosphorylation</li>
                                            <li>Fatty acid oxidation</li>
                                        </ul>
                                    </li>
                                </ul>
                            </li>
                        </ul>
                        <h3 class="subsection-heading">DCM: inherited</h3>
                        <h4>Familial cardiomyopathy</h4>
                        <ul>
                            <li>30% of 'idiopathic'</li>
                            <li>Inheritance patterns
                                <ul>
                                    <li>Autosomal dom/rec, x-linked, mitochondrial</li>
                                </ul>
                            </li>
                            <li>Associated phenotypes:
                                <ul>
                                    <li>Skeletal muscle abn, neurologic, auditory</li>
                                </ul>
                            </li>
                            <li>Mechanism:
                                <ul>
                                    <li>Abnormalities in:
                                        <ul>
                                            <li>Energy production</li>
                                            <li>Contractile force generation</li>
                                        </ul>
                                    </li>
                                    <li>Specific genes coding for:
                                        <ul>
                                            <li>Myosin, actin, dystrophin...</li>
                                        </ul>
                                    </li>
                                </ul>
                            </li>
                        </ul>
                        <h3 class="subsection-heading">DCM: Peripartum</h3>
                        <h4>Diagnostic Criteria</h4>
                        <ul>
                            <li>1 mo pre, 5 mos post</li>
                            <li>Echo: LV dysfunction
                                <ul>
                                    <li>LVEF < 45%</li>
                                    <li>LVEDD > 2.7 cm/m2</li>
                                </ul>
                            </li>
                        </ul>
                        <h4>Epidemiology/Etiology</h4>
                        <ul>
                            <li>1:4000 women</li>
                        </ul>
                        <p><small>Reference: JAMA 2000;283:1183</small></p>
                        <h4>Proposed mechanisms:</h4>
                        <ul>
                            <li>Inflammatory Cytokines:
                                <ul>
                                    <li>TNFa, IL6, Fas/AP01</li>
                                </ul>
                            </li>
                        </ul>
                        <p><small>Reference: JACC 2000 35(3):701.</small></p>
                    </div>
                </section>
                <!-- END: dilated-cardiomyopathy -->

                <!-- START: hf-mechanisms -->
                <section id="hf-mechanisms" class="content-section" aria-labelledby="section-heading-4">
                    <h2 id="section-heading-4" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">MECHANISMS IN HEART FAILURE</span>
                    </h2>
                    <div class="content-card">
                         <p>Pathological stimuli (Ischemic injury, Myocardial disease, Genetics) lead to:</p>
                        <ul>
                            <li>Neurohormones</li>
                            <li>Cytokines</li>
                            <li>Oxidative stress</li>
                        </ul>
                        <p>This results in:</p>
                        <ul>
                            <li>Altered molecular expression</li>
                            <li>Ultrastructural changes</li>
                            <li>Myocyte hypertrophy</li>
                            <li>Myocyte contractile dysfunction</li>
                            <li>Apoptosis</li>
                            <li>Fibroblast proliferation</li>
                            <li>Collagen deposition</li>
                        </ul>
                        <p>Which causes:</p>
                        <ul>
                            <li>Ventricular remodeling</li>
                        </ul>
                        <p>Leading to:</p>
                        <ul>
                            <li>Hemodynamic Derangement</li>
                            <li>Clinical Heart Failure</li>
                            <li>Arrhythmia</li>
                        </ul>
                    </div>
                </section>
                <!-- END: hf-mechanisms -->
                
                <!-- START: dcm-pathophysiology -->
                <section id="dcm-pathophysiology" class="content-section" aria-labelledby="section-heading-5">
                    <h2 id="section-heading-5" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Pathophysiology</span>
                    </h2>
                    <div class="content-card">
                        <p>Initial Compensation for impaired myocyte contractility:</p>
                        <ul>
                            <li>Frank-Starling mechanism</li>
                            <li>Neurohumoral activation</li>
                            <li>↑ intravascular volume</li>
                        </ul>
                        <p>Eventual decompensation</p>
                        <ul>
                            <li>ventricular remodeling</li>
                            <li>myocyte death/apoptosis</li>
                            <li>valvular regurgitation</li>
                        </ul>
                        <h3 class="subsection-heading">Pathophysiology: Neurohumoral</h3>
                        <ul>
                            <li>Adrenergic nervous system</li>
                            <li>Renin-angiotensin-aldosterone axis</li>
                            <li>Vasopressin</li>
                            <li>Natriuretic peptides</li>
                            <li>Endothelin</li>
                        </ul>
                        <figure>
                            <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-13-1.jpg" alt="Graph showing median plasma norepinephrine levels in different NYHA classes and normals." class="content-image">
                            <figcaption>MEDIAN PLASMA NOREPINEPHRINE LEVELS (pg/mL). From: Francis. Circulation. 1990;82:1724-1729.</figcaption>
                        </figure>
                        <h3 class="subsection-heading">Renin-Angiotensin-Aldosterone Pathways</h3>
                        <figure>
                            <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-14-1.jpg" alt="Diagram of the Renin-Angiotensin-Aldosterone system pathways and their effects." class="content-image">
                        </figure>
                        <h3 class="subsection-heading">Angiotensin-II Effects</h3>
                        <ul>
                            <li>Vasoconstriction</li>
                            <li>Aldosterone production</li>
                            <li>Myocyte hypertrophy</li>
                            <li>Fibroblast proliferation</li>
                            <li>Collagen deposition</li>
                            <li>Apoptosis</li>
                            <li>Pro-thrombotic</li>
                            <li>Pro-oxidant</li>
                            <li>Adrenergic stimulation</li>
                            <li>Endothelial dysfunction</li>
                        </ul>
                        <h3 class="subsection-heading">The Kidney in Heart Failure</h3>
                        <ul>
                            <li>Reduced renal blood flow</li>
                            <li>Reduced glomerular filtration rate</li>
                            <li>Increased renin production</li>
                            <li>Increased tubular sodium reabsorption</li>
                            <li>Increased free water retention (vasopressin)</li>
                        </ul>
                    </div>
                </section>
                <!-- END: dcm-pathophysiology -->

                <!-- START: clinical-findings -->
                <section id="clinical-findings" class="content-section" aria-labelledby="section-heading-6">
                    <h2 id="section-heading-6" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Clinical Findings</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Biventricular Congestive Heart Failure</h3>
                        <ul>
                            <li>Low forward Cardiac Output
                                <ul>
                                    <li>fatigue, lightheadedness, hypotension</li>
                                </ul>
                            </li>
                            <li>Pulmonary Congestion
                                <ul>
                                    <li>Dyspnea, orthopnea, & PND</li>
                                </ul>
                            </li>
                            <li>Systemic Congestion
                                <ul>
                                    <li>Edema</li>
                                    <li>Ascites</li>
                                    <li>Weight gain</li>
                                </ul>
                            </li>
                        </ul>
                        <h3 class="subsection-heading">Physical Exam</h3>
                        <ul>
                            <li><strong>Decreased C.O.</strong>
                                <ul>
                                    <li>Tachycardia</li>
                                    <li>↓ BP and pulse pressure</li>
                                    <li>cool extremities (vasoconstriction)</li>
                                    <li>Pulsus Alternans (end-stage)</li>
                                </ul>
                            </li>
                            <li><strong>Pulmonary venous congestion:</strong>
                                <ul>
                                    <li>rales</li>
                                    <li>pleural effusions</li>
                                </ul>
                            </li>
                            <li><strong>Cardiac:</strong>
                                <ul>
                                    <li>laterally displaced PMI</li>
                                    <li>S3 (acutely)</li>
                                    <li>mitral regurgitation murmur</li>
                                </ul>
                            </li>
                            <li><strong>Systemic congestion</strong>
                                <ul>
                                    <li>↑ JVD</li>
                                    <li>hepatosplenomegaly</li>
                                    <li>ascites</li>
                                    <li>peripheral edema</li>
                                </ul>
                            </li>
                        </ul>
                    </div>
                </section>
                <!-- END: clinical-findings -->

                <!-- START: diagnostic-studies -->
                <section id="diagnostic-studies" class="content-section" aria-labelledby="section-heading-7">
                    <h2 id="section-heading-7" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Diagnostic Studies</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li><strong>CXR</strong> - enlarged cardiac silhouette, vascular redistribution interstitial edema, pleural effusions</li>
                            <li><strong>EKG</strong> - normal tachycardia, atrial and ventricular enlargement, LBBB, RBBB, Q-waves</li>
                            <li><strong>Blood Tests</strong> (ANA,RF, Fe²⁺, TFT's, ferritin,)</li>
                            <li><strong>Echocardiography</strong> - LV size, wall thickness function valve dz, pressures</li>
                            <li><strong>Cardiac Catheterization</strong> - hemodynamics, LVEF, angiography</li>
                            <li><strong>Endomyocardial Biopsy</strong></li>
                        </ul>
                    </div>
                </section>
                <!-- END: diagnostic-studies -->
                
                <!-- START: nyha-classification -->
                <section id="nyha-classification" class="content-section" aria-labelledby="section-heading-8">
                    <h2 id="section-heading-8" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Criteria for NYHA Functional Classification</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li><strong>Class 1:</strong> No limitation of physical activity. Ordinary physical activity w/o fatigue, palpitation, or dyspnea.</li>
                            <li><strong>Class 2:</strong> Slight limitation of physical activity. Comfortable at rest, but symptoms w/ ordinary physical activity.</li>
                            <li><strong>Class 3:</strong> Marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes fatigue, palpitation, or dyspnea.</li>
                            <li><strong>Class 4:</strong> Unable to carry out any physical activity without discomfort. Symptoms include cardiac insufficiency at rest. If any physical activity is undertaken, discomfort is increased.</li>
                        </ul>
                    </div>
                </section>
                <!-- END: nyha-classification -->

                <!-- START: treatment -->
                <section id="treatment" class="content-section" aria-labelledby="section-heading-9">
                    <h2 id="section-heading-9" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Treatment</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Aim of Treatment</h3>
                        <ul>
                            <li>Preload reduction
                                <ul>
                                    <li>Diuretics</li>
                                    <li>venodilators</li>
                                </ul>
                            </li>
                            <li>Vasodilators
                                <ul>
                                    <li>ACEI</li>
                                </ul>
                            </li>
                            <li>Inotropes
                                <ul>
                                    <li>Acutely</li>
                                    <li>Chronically - mortality</li>
                                </ul>
                            </li>
                        </ul>
                        <figure>
                            <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-21-1.jpg" alt="Diagram showing the Frank-Starling curve and the effects of vasodilators and inotropes on cardiac output in heart failure." class="content-image">
                        </figure>
                        <h3 class="subsection-heading">Vasodilator Agents in Heart Failure</h3>
                        <div class="table-container">
                            <table class="content-table">
                                <thead>
                                    <tr>
                                        <th>Drug</th>
                                        <th>Mechanism</th>
                                        <th>Action</th>
                                        <th>Use</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td>Nitroglycerin and long-acting nitrates*</td>
                                        <td>Direct via nitric oxide</td>
                                        <td>Veno / arteriolar</td>
                                        <td>Hemodynamic; anti-ischemic; long term</td>
                                    </tr>
                                    <tr>
                                        <td>Nitroprusside</td>
                                        <td>Direct via nitric oxide</td>
                                        <td>Arteriolar > venodilation</td>
                                        <td>Hemodynamic</td>
                                    </tr>
                                    <tr>
                                        <td>Hydralazine*</td>
                                        <td>Direct</td>
                                        <td>Arteriolar</td>
                                        <td>?long term*</td>
                                    </tr>
                                    <tr>
                                        <td>ACE inhibitors#</td>
                                        <td>Reduced A-II Incr. bradykinin</td>
                                        <td>Veno / arteriolar</td>
                                        <td>Long-term</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                        <p><small>*Hydralazine and a long-nitrate shown to reduce mortality long-term<br># Other actions (aside from vasodilation) likely to be important</small></p>

                        <h3 class="subsection-heading">CRT: Cardiac Resynchronization Therapy</h3>
                        <ol>
                            <li>Improved hemodynamics
                                <ul>
                                    <li>Increased CO</li>
                                    <li>Reduced LV filling pressures</li>
                                    <li>Reduced sympathetic activity</li>
                                    <li>Increased systolic function w/o MVO2</li>
                                </ul>
                            </li>
                            <li>Reverse LV remodeling/architecture
                                <ul>
                                    <li>Decreased LVES/ED volumes</li>
                                    <li>Increased LVEF</li>
                                </ul>
                            </li>
                        </ol>
                        <p><small>References: Circ '02, JACC '02, JACC '02, NEJM'02</small></p>
                        <figure>
                            <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-23-1.jpg" alt="Echocardiogram before and after cardiac resynchronization therapy (CRT), showing improved ventricular synchrony." class="content-image">
                        </figure>
                        
                        <figure>
                             <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-24-1.jpg" alt="Graph showing survival curves for patients treated with anti-arrhythmic drugs, ICD, and placebo." class="content-image">
                             <figcaption>Anti-arrhythmic drugs, ICD placebo and Death</figcaption>
                        </figure>
                    </div>
                </section>
                <!-- END: treatment -->
                
                <!-- START: diastolic-dysfunction -->
                <section id="diastolic-dysfunction" class="content-section" aria-labelledby="section-heading-10">
                    <h2 id="section-heading-10" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Diastolic Dysfunction</span>
                    </h2>
                    <div class="content-card">
                         <p>40-50% of pts w/ CHF have nml LVEF</p>
                        <ul>
                            <li>Vasan JACC '99</li>
                            <li>Grossman Circ '00</li>
                        </ul>
                        <p>Prevalence:</p>
                        <ul>
                            <li>increases with age</li>
                            <li>higher in women</li>
                        </ul>
                        <p>Etiology: HTN & LVH</p>
                        <p>Diagnosis:</p>
                        <ul>
                            <li>MV& PV Doppler</li>
                            <li>TDI, Color m-mode</li>
                        </ul>
                        <figure>
                            <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-25-1.jpg" alt="Doppler echocardiogram showing patterns of diastolic dysfunction." class="content-image">
                        </figure>
                    </div>
                </section>
                <!-- END: diastolic-dysfunction -->

                <!-- START: hypertrophic-cardiomyopathy -->
                <section id="hypertrophic-cardiomyopathy" class="content-section" aria-labelledby="section-heading-11">
                    <h2 id="section-heading-11" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Hypertrophic Cardiomyopathy</span>
                    </h2>
                    <div class="content-card">
                        <p>Left ventricular hypertrophy not due to pressure overload Hypertrophy is variable in both severity and location:</p>
                        <ul>
                            <li>asymmetric septal hypertrophy</li>
                            <li>symmetric (non-obstructive)</li>
                            <li>apical hypertrophy</li>
                        </ul>
                        <p>Vigorous systolic function, but impaired diastolic function, impaired relaxation of ventricles, elevated diastolic pressures. Prevalence as high as 1/500 in general population. Mortality in selected populations 4-6% (institutional) probably more favorable (≤ 1%).</p>
                        <h3 class="subsection-heading">Etiology</h3>
                        <p>Familial in ~ 55% of cases with autosomal dominant transmission. Mutations in one of 4 genes encoding proteins of cardiac sarcomere account for majority of familial cases:</p>
                        <ul>
                            <li>β-MHC</li>
                            <li>cardiac troponin T</li>
                            <li>myosin binding protein C</li>
                            <li>α-tropomyosin</li>
                        </ul>
                        <p>Remainder are spontaneous mutations.</p>
                        <figure>
                            <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-27-1.jpg" alt="Diagram of the cardiac sarcomere, showing proteins like myosin, actin, and troponin." class="content-image">
                        </figure>
                        <figure>
                            <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-28-1.jpg" alt="Gross pathology image of a heart with hypertrophic cardiomyopathy." class="content-image">
                        </figure>
                        <figure>
                            <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-29-1.jpg" alt="Microscopic image showing myocyte disarray in hypertrophic cardiomyopathy." class="content-image">
                        </figure>
                        <figure>
                            <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-30-1.jpg" alt="Echocardiogram showing asymmetric septal hypertrophy in HCM." class="content-image">
                            <figcaption>Lossy compression - not intended for diagnosis</figcaption>
                        </figure>
                        <figure>
                            <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-31-1.jpg" alt="Echocardiogram showing systolic anterior motion (SAM) of the mitral valve in HCM." class="content-image">
                        </figure>
                        <h3 class="subsection-heading">Pathophysiology</h3>
                        <figure>
                            <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-32-1.jpg" alt="Flowchart explaining the pathophysiology of hypertrophic cardiomyopathy." class="content-image">
                        </figure>
                        <h3 class="subsection-heading">HCM with outflow obstruction</h3>
                        <p>Dynamic LVOT obstruction (may not be present at rest)</p>
                        <ul>
                            <li>SAM(systolic anterior motion of mitral valve)</li>
                            <li>LVOT Obstruction ⇒ LVOT gradient ⇒ ↑wall stress ⇒ ↑MVO2 ⇒ ischemia/angina</li>
                            <li>↑LVOT gradient: ↑HR (DFP), ↓preload (LVEDV), ↓afterload(BP).</li>
                            <li>↓LVOT gradient: ↑BP (Afterload), ↑LVEDV(preload)</li>
                        </ul>
                        <figure>
                            <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-33-1.jpg" alt="Echocardiogram showing systolic anterior motion (SAM) of the mitral valve leading to LVOT obstruction." class="content-image">
                        </figure>
                        <p>Symptoms of dyspnea and angina more related to diastolic dysfunction than to outflow tract obstruction. Syncope: LVOT obstruction (failure to increase CO during exercise or after vasodilatory stress) or arrhythmia.</p>
                    </div>
                </section>
                <!-- END: hypertrophic-cardiomyopathy -->

                <!-- START: hcm-physical-exam -->
                <section id="hcm-physical-exam" class="content-section" aria-labelledby="section-heading-12">
                    <h2 id="section-heading-12" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Physical Exam (HCM)</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Bisferiens pulse ("spike and dome")</li>
                            <li>S4 gallop</li>
                            <li>Crescendo/Descrescendo systolic ejection murmur</li>
                        </ul>
                        <h3 class="subsection-heading">HOCM vs. Valvular AS</h3>
                        <ul>
                            <li>Valsalva (↓preload, ↓afterload)</li>
                            <li>Squatting (↑preload, ↑afterload)</li>
                            <li>Standing (↓preload, ↓afterload)</li>
                        </ul>
                        <p>Intensity of murmur</p>
                        <p>Holosystolic apical blowing murmur of mitral regurgitation</p>
                    </div>
                </section>
                <!-- END: hcm-physical-exam -->
                
                <!-- START: hcm-diagnostics -->
                <section id="hcm-diagnostics" class="content-section" aria-labelledby="section-heading-13">
                    <h2 id="section-heading-13" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Diagnostic Studies (HCM)</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li><strong>EKG</strong>
                                <ul>
                                    <li>NSR</li>
                                    <li>LVH</li>
                                    <li>septal Q waves</li>
                                </ul>
                            </li>
                            <li><strong>2D-Echocardiography</strong>
                                <ul>
                                    <li>LVH; septum >1.4x free wall</li>
                                    <li>LVOT gradient by Doppler</li>
                                    <li>Systolic anterior motion of the mitral valve regurgitation</li>
                                </ul>
                            </li>
                            <li><strong>Cardiac Catheterization</strong>
                                <ul>
                                    <li>LVOT gradient and pullback</li>
                                    <li>provocative maneuvers</li>
                                    <li>Brockenbrough phenomenon</li>
                                </ul>
                            </li>
                        </ul>
                        <figure>
                            <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-35-1.jpg" alt="Contrast echocardiogram showing asymmetric septal hypertrophy (ASH) in HCM." class="content-image">
                            <figcaption>HCM-ASH using contrast</figcaption>
                        </figure>
                        <h3 class="subsection-heading">Cardiac Catheterization</h3>
                        <figure>
                            <figcaption>LV pullback</figcaption>
                            <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-36-1.jpg" alt="Pressure tracing from an LV pullback in HOCM, showing a significant gradient." class="content-image">
                        </figure>
                        <figure>
                            <figcaption>Brockenbrough-Braunwald Sign: failure of aortic pulse pressure to rise post PVC</figcaption>
                            <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-36-2.jpg" alt="Pressure tracing demonstrating the Brockenbrough-Braunwald sign." class="content-image">
                        </figure>
                        <figure>
                            <figcaption>Provocative maneuvers: Valsalva, amyl nitrate inhalation</figcaption>
                             <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-36-3.jpg" alt="Pressure tracing showing increased LVOT gradient with provocative maneuvers." class="content-image">
                        </figure>
                    </div>
                </section>
                <!-- END: hcm-diagnostics -->
                
                <!-- START: hcm-complications-treatment -->
                <section id="hcm-complications-treatment" class="content-section" aria-labelledby="section-heading-14">
                    <h2 id="section-heading-14" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">HCM: Complications and Treatment</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Atrial Fibrillation</h3>
                        <p>Acute A. Fib is poorly tolerated - Acute Pulmonary Edema and Shock. Chronic a fib - Fatigue, dyspnea and angina.</p>
                        <ul>
                            <li>Rapid HR - decreased time for diastolic filling and LV relaxation</li>
                            <li>Loss of atrial "Kick" - decreased LV filling - decreased SV and increased outflow tract obstruction</li>
                        </ul>
                        <p>Rate slowing with β-blockers and Ca2+ channel blockers. Digitalis is relatively contra-indicated- positive inotrope. DC Cardioversion.</p>
                        <h3 class="subsection-heading">Treatment</h3>
                        <p>For symptomatic benefit</p>
                        <ul>
                            <li>β-blockers: ↓ MVO2, ↓ gradient (exercise), arrythmias</li>
                            <li>Calcium Channel blockers</li>
                            <li>Anti-arrhythmics: afib, amiodarone</li>
                            <li>Disopyramide</li>
                            <li>AICD for sudden death</li>
                            <li>antibiotic prophylaxis for endocarditis</li>
                        </ul>
                        <p>No therapy has been shown to improve mortality.</p>
                        <h3 class="subsection-heading">HCM: Surgical Treatment</h3>
                        <p>For severe symptoms with large outflow gradient (>50 mmHg). Does not prevent Sudden Cardiac Death.</p>
                        <ul>
                            <li><strong>Myomyectomy</strong>
                                <ul>
                                    <li>removal of small portion of upper IV septum</li>
                                    <li>+/- mitral valve replacement</li>
                                    <li>5 year symptomatic benefit in ~ 70% of patients</li>
                                </ul>
                            </li>
                            <li><strong>Dual Chamber (DDD pacemaker) pacing</strong>
                                <ul>
                                    <li>decreases LVOT gradient (by ~25%)</li>
                                    <li>randomized trials have shown little longterm benefit</li>
                                    <li>possible favorable morphologic changes</li>
                                </ul>
                            </li>
                            <li><strong>ETOH septal ablation</strong></li>
                            <li><strong>AICD to prevent sudden death</strong></li>
                        </ul>
                    </div>
                </section>
                <!-- END: hcm-complications-treatment -->

                <!-- START: hcm-prognosis -->
                <section id="hcm-prognosis" class="content-section" aria-labelledby="section-heading-15">
                     <h2 id="section-heading-15" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">HCM: Prognosis and Risk</span>
                    </h2>
                    <div class="content-card">
                        <p>Most common cause of death in young people. The magnitude of left ventricular hypertrophy is directly correlated to the risk of SCD. Young pts with extreme hypertrophy and few or no symptoms are at substantial long-term risk of SCD.</p>
                        <h3 class="subsection-heading">Prognosis</h3>
                        <p><strong>Sudden Death</strong></p>
                        <ul>
                            <li>2-4%/year in adults</li>
                            <li>4-6% in children/adolescents</li>
                        </ul>
                        <p><strong>AICD for:</strong></p>
                        <ul>
                            <li>survivors of SCD with Vfib</li>
                            <li>episodes of Sustained VT</li>
                            <li>pts with family hx of SCD in young family members</li>
                            <li>High risk mutation (TnT, Arg403Gln)</li>
                        </ul>
                        <p><strong>Predictors of adverse prognosis:</strong></p>
                        <ul>
                            <li>early age of diagnosis</li>
                            <li>familial form with SCD in 1st degree relative</li>
                            <li>history of syncope</li>
                            <li>ischemia</li>
                            <li>presence of ventricular arrhythmias on Holter (EPS)</li>
                        </ul>
                        <p>EPS, Amiodarone (low dose), Prophylactic AICD?</p>
                    </div>
                </section>
                <!-- END: hcm-prognosis -->

                <!-- START: restrictive-cardiomyopathy -->
                <section id="restrictive-cardiomyopathy" class="content-section" aria-labelledby="section-heading-16">
                    <h2 id="section-heading-16" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Restrictive Cardiomyopathy</span>
                    </h2>
                    <div class="content-card">
                        <p>Characterized by:</p>
                        <ul>
                            <li>impaired ventricular filling due to an abnormally stiff (rigid) ventricle</li>
                            <li>normal systolic function (early on in disease)</li>
                            <li>intraventricular pressure rises precipitously with small increases in volume</li>
                        </ul>
                        <figure>
                            <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-42-1.jpg" alt="Pressure-volume loop illustrating the pathophysiology of restrictive cardiomyopathy." class="content-image">
                        </figure>
                        <p><strong>Causes:</strong> infiltration of myocardium by abnormal substance, fibrosis or scarring of endocardium.</p>
                        <figure>
                            <figcaption>Amyloid infiltrative CM</figcaption>
                            <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-43-1.jpg" alt="Echocardiogram showing granular sparkling texture typical of amyloid cardiomyopathy." class="content-image">
                        </figure>
                        <h4>Myocardial</h4>
                        <ul>
                            <li><strong>Noninfiltrative disorders</strong>
                                <ul>
                                    <li>Idiopathic disease</li>
                                    <li>Familial disease</li>
                                    <li>Hypertrophy</li>
                                    <li>Scleroderma</li>
                                    <li>Diabetes mellitus</li>
                                    <li>Pseudoxanthoma elasticum</li>
                                </ul>
                            </li>
                            <li><strong>Infiltrative disorders</strong>
                                <ul>
                                    <li>Amyloidosis</li>
                                    <li>Sarcoidosis</li>
                                    <li>Gaucher's disease</li>
                                    <li>Hurler's syndrome</li>
                                    <li>Fatty infiltration</li>
                                </ul>
                            </li>
                            <li><strong>Storage disorders</strong>
                                <ul>
                                    <li>Hemochromatosis</li>
                                    <li>Fabry's disease</li>
                                    <li>Glycogen storage disease</li>
                                </ul>
                            </li>
                        </ul>
                        <h4>Endomyocardial</h4>
                        <ul>
                            <li>Endomyocardial fibrosis</li>
                            <li>Hypereosinophilic (Löffler's) syndrome</li>
                            <li>Carcinoid syndrome</li>
                            <li>Metastatic cancer</li>
                            <li>Exposure to radiation</li>
                            <li>Toxins
                                <ul>
                                    <li>Anthracycline (doxorubicin or daunorubicin)</li>
                                    <li>Serotonin</li>
                                    <li>Methysergide</li>
                                    <li>Ergotamine</li>
                                    <li>Mercurial agents</li>
                                    <li>Busulfan</li>
                                </ul>
                            </li>
                        </ul>
                        <h3 class="subsection-heading">Amyloidosis</h3>
                        <ul>
                            <li><strong>Primary Amyloidosis</strong>
                                <ul>
                                    <li>immunoglobulin light chains -- multiple myeloma</li>
                                </ul>
                            </li>
                            <li><strong>Secondary Amyloidosis</strong>
                                <ul>
                                    <li>deposition of protein other than immunoglobulin</li>
                                    <li>senile</li>
                                    <li>familial</li>
                                    <li>chronic inflammatory process</li>
                                </ul>
                            </li>
                        </ul>
                        <p>restriction caused by replacement of normal myocardial contractile elements by infiltrative interstitial deposits.</p>
                        <figure>
                            <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-45-1.jpg" alt="Histopathology slide showing amyloid deposits in the myocardium." class="content-image">
                        </figure>
                        <figure>
                            <figcaption>Amyloid Cardiomyopathy</figcaption>
                            <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-46-1.jpg" alt="Gross pathology of a heart with amyloid cardiomyopathy." class="content-image">
                        </figure>
                        <h3 class="subsection-heading">Sarcoidosis</h3>
                        <figure>
                             <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-47-1.jpg" alt="Histopathology slide showing non-caseating granulomas of cardiac sarcoidosis." class="content-image">
                        </figure>
                        <ul>
                            <li>Restriction</li>
                            <li>Conduction System Disease</li>
                            <li>Ventricular Arrhythmias (Sudden Cardiac Death)</li>
                        </ul>
                        <h3 class="subsection-heading">Endomyocardial Fibrosis</h3>
                        <p>Endemic in parts of Africa, India, South and Central America, Asia. 15-25% of cardiac deaths in equatorial Africa. Hypereosinophilic syndrome (Loffler's endocarditis).</p>
                        <figure>
                            <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-48-1.jpg" alt="Image showing endomyocardial fibrosis." class="content-image">
                        </figure>
                        <p>Thickening of basal inferior wall, endocardial deposition of thrombus, apical obliteration, mitral regurgitation. 80-90% die within 1-2 years.</p>
                    </div>
                </section>
                <!-- END: restrictive-cardiomyopathy -->

                <!-- START: rcm-pathophysiology-clinical -->
                <section id="rcm-pathophysiology-clinical" class="content-section" aria-labelledby="section-heading-17">
                    <h2 id="section-heading-17" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">RCM: Pathophysiology and Clinical Findings</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Pathophysiology of Restriction</h3>
                        <figure>
                            <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-49-1.jpg" alt="Pressure-volume loops comparing normal, systolic dysfunction, and diastolic dysfunction." class="content-image">
                        </figure>
                        <p>Elevated systemic and pulmonary venous pressures, right and left sided congestion, reduced ventricular cavity size with ↓ SV and ↓ CO.</p>
                        <h3 class="subsection-heading">Clinical Findings</h3>
                        <p>Right > Left heart failure</p>
                        <ul>
                            <li>Dyspnea</li>
                            <li>Orthopnea/PND</li>
                            <li>Peripheral edema</li>
                            <li>Ascites/Hepatomegaly</li>
                            <li>Fatigue/↓ exercise tolerance</li>
                        </ul>
                        <p>Clinically mimics constrictive Pericarditis</p>
                    </div>
                </section>
                <!-- END: rcm-pathophysiology-clinical -->

                <!-- START: rcm-diagnostics-treatment -->
                <section id="rcm-diagnostics-treatment" class="content-section" aria-labelledby="section-heading-18">
                    <h2 id="section-heading-18" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">RCM: Diagnostics and Treatment</span>
                    </h2>
                    <div class="content-card">
                         <h3 class="subsection-heading">Diagnostic Studies</h3>
                        <ul>
                            <li>2D-Echo/Doppler: mitral in-flow velocity rapid early diastolic filling</li>
                            <li>Catheterization - diastolic pressure equilibration, restrictive vs constrictive hemodynamics</li>
                            <li>Endomyocardial biopsy: definite Dx of restrictive pathology</li>
                        </ul>
                        <figure>
                            <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-51-1.jpg" alt="Doppler echocardiogram showing mitral inflow pattern in restrictive cardiomyopathy." class="content-image">
                        </figure>
                        <h3 class="subsection-heading">Cardiac Catheterization</h3>
                        <figure>
                            <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-52-1.jpg" alt="Pressure tracings from cardiac catheterization in restrictive cardiomyopathy." class="content-image">
                            <figcaption>Prominent y descent rapid atrial emptying, "dip and plateau" rapid ventricular filling then abrupt cessation of blood flow due to non-compliant myocardium.</figcaption>
                        </figure>
                        <h3 class="subsection-heading">Constriction vs. Restrictive CM</h3>
                        <div class="table-container">
                            <table class="content-table">
                                <caption>The Differential Diagnosis of Restrictive Cardiomyopathy and Constrictive Pericarditis.*</caption>
                                <thead>
                                    <tr>
                                        <th>Type of Evaluation</th>
                                        <th>Restrictive Cardiomyopathy</th>
                                        <th>Constrictive Pericarditis</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td><strong>Physical examination</strong></td>
                                        <td>Kussmaul's sign may be present. Apical impulse may be prominent. S3 may be present, rarely S4. Regurgitant murmurs common.</td>
                                        <td>Kussmaul's sign usually present. Apical impulse usually not palpable. Pericardial knock may be present. Regurgitant murmurs uncommon.</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Electrocardiography</strong></td>
                                        <td>Low voltage (especially in amyloidosis), pseudoinfarction, left-axis deviation, atrial fibrillation, conduction disturbances common.</td>
                                        <td>Low voltage (<50 percent).</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Echocardiography</strong></td>
                                        <td>Increased wall thickness (especially thickened interatrial septum in amyloidosis). Thickened cardiac valves (amyloidosis). Granular sparkling texture (amyloid).</td>
                                        <td>Normal wall thickness. Pericardial thickening may be seen. Prominent early diastolic filling with abrupt displacement of interventricular septum.</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Doppler studies</strong></td>
                                        <td>Decreased RV and LV velocities with inspiration. Inspiratory augmentation of hepatic-vein diastolic flow reversal. Mitral and tricuspid regurgitation common.</td>
                                        <td>Increased RV systolic velocity and decreased LV systolic velocity with inspiration. Expiratory augmentation of hepatic-vein diastolic flow reversal.</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Cardiac catheterization</strong></td>
                                        <td>LVEDP often >5 mm Hg greater than RVEDP, but may be identical.</td>
                                        <td>RVEDP and LVEDP usually equal. RV systolic pressure <50 mm Hg. RVEDP >one third of RV systolic pressure.</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Endomyocardial biopsy</strong></td>
                                        <td>May reveal specific cause of restrictive cardiomyopathy.</td>
                                        <td>May be normal or show nonspecific myocyte hypertrophy or myocardial fibrosis.</td>
                                    </tr>
                                    <tr>
                                        <td><strong>CT/MRI</strong></td>
                                        <td>Pericardium usually normal.</td>
                                        <td>Pericardium may be thickened.</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                        <p><small>*LV denotes left ventricular, RV right ventricular, LVEDP left ventricular end-diastolic pressure, RVEDP right ventricular end-diastolic pressure, CT computed tomography, and MRI magnetic resonance imaging.</small></p>

                        <h3 class="subsection-heading">Treatment</h3>
                        <ul>
                            <li>Treat underlying cause</li>
                            <li>r/o constriction which is treatable (restriction poor prognosis)</li>
                            <li>amyloid (melphalan/prednisone/colchicine)</li>
                            <li>Endomyocardial Fibrosis (steroids, cytotoxic drugs, MVR)</li>
                            <li>Hemochromatosis (chelation, phlebotomy)</li>
                            <li>Sarcoidosis (steroids)</li>
                            <li>Diuretics for congestive symptoms, but ↓ LV/RV filling ⇒ ↓ CO</li>
                            <li>Digoxin (avoid in amyloidosis)</li>
                            <li>Antiarrhythmics for afib amiodarone</li>
                            <li>Pacemaker for conduction system disease</li>
                            <li>Anticoagulation for thrombus (esp in atrial appendages)</li>
                        </ul>
                    </div>
                </section>
                <!-- END: rcm-diagnostics-treatment -->
                
                <!-- START: arvd-lvnc -->
                <section id="arvd-lvnc" class="content-section" aria-labelledby="section-heading-19">
                     <h2 id="section-heading-19" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Other Cardiomyopathies</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Arrhythmogenic RV Dysplasia</h3>
                        <ul>
                            <li>Myocardium of RV free wall replaced:
                                <ul>
                                    <li>Fibrofatty tissue</li>
                                </ul>
                            </li>
                            <li>Regional wall motion/function is reduced</li>
                            <li>Ventricular arrhythmias</li>
                            <li>SCD in young</li>
                        </ul>
                        <h3 class="subsection-heading">MRI: RV Dysplasia</h3>
                        <figure>
                            <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-55-1.jpg" alt="MRI image showing features of arrhythmogenic right ventricular dysplasia." class="content-image">
                        </figure>

                        <h3 class="subsection-heading">LV Noncompaction</h3>
                        <h4>Diagnostic Criteria</h4>
                        <ul>
                            <li>Prominent trabeculations, deep recesses in LV apex</li>
                            <li>Thin compact epicardium, thickened endocardium</li>
                            <li><small>Stollberger C, JASE `04</small></li>
                            <li>Other phenotypic findings</li>
                        </ul>
                        <h4>Prognosis and Treatment</h4>
                        <ul>
                            <li>Increased risk of CHF, VT/SCD, thrombosis</li>
                            <li><small>Oechslin EN, JACC '00</small></li>
                            <li>Hereditary risk</li>
                            <li>Screening of offspring</li>
                            <li>Pregnancy: case report</li>
                        </ul>
                         <figure>
                            <figcaption>Echo: LV Noncompaction</figcaption>
                            <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-58-1.jpg" alt="Echocardiogram showing prominent trabeculations characteristic of LV noncompaction." class="content-image">
                        </figure>
                    </div>
                </section>
                <!-- END: arvd-lvnc -->
                
                <!-- START: summary-classification -->
                <section id="summary-classification" class="content-section" aria-labelledby="section-heading-20">
                     <h2 id="section-heading-20" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Cardiomyopathy WHO Classification Summary</span>
                    </h2>
                    <div class="content-card">
                        <p>anatomy & physiology of the LV</p>
                        <ol>
                            <li>Dilated
                                <ul>
                                    <li>Enlarged</li>
                                    <li>Systolic dysfunction</li>
                                </ul>
                            </li>
                            <li>Hypertrophic
                                <ul>
                                    <li>Thickened</li>
                                    <li>Diastolic dysfunction</li>
                                </ul>
                            </li>
                            <li>Restrictive
                                <ul>
                                    <li>Myocardial stiffness</li>
                                    <li>Diastolic dysfunction</li>
                                </ul>
                            </li>
                            <li>Arrhythmogenic RV dysplasia
                                <ul>
                                    <li>Fibrofatty replacement</li>
                                </ul>
                            </li>
                            <li>Unclassified
                                <ul>
                                    <li>Fibroelastosis</li>
                                    <li>LV noncompaction</li>
                                </ul>
                            </li>
                        </ol>
                        <figure>
                            <img src="../assets/images/2025_06_29_9e21e2ed186ec86e28d7g-59-1.jpg" alt="Diagram illustrating the gross morphological differences between dilated, hypertrophic, and restrictive cardiomyopathies." class="content-image">
                        </figure>
                    </div>
                </section>
                <!-- END: summary-classification -->
            </main>

            <!-- Bottom Navigation -->
             <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="cardiology-pericardial-effusion.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 65.4%;"></div>
                        </div>
                       <span class="progress-text">Lecture 34 of 52</span>
                    </div>
                    <a href="cardiology-cardiomyopathies-9A-styled.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>
</html>